Collectively, our results provide experimental evidence regarding the clinical significance and biological role of MFSD4A-AS1 in lymphatic metastasis of PTC, which will facilitate early detection of lymph node metastasis and the development of anti-lymph node metastasis therapeutic methods in PTC patients. This evidence concerns the gene SLC60A1 and metastatic malignant neoplasm in the lymph nodes.